These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gabapentin in the management of convulsive disorders. McLean MJ Epilepsia; 1999; 40 Suppl 6():S39-50; discussion S73-4. PubMed ID: 10530682 [TBL] [Abstract][Full Text] [Related]
4. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Backonja M; Glanzman RL Clin Ther; 2003 Jan; 25(1):81-104. PubMed ID: 12637113 [TBL] [Abstract][Full Text] [Related]
5. Gabapentin: a new agent for the management of epilepsy. Andrews CO; Fischer JH Ann Pharmacother; 1994 Oct; 28(10):1188-96. PubMed ID: 7841578 [TBL] [Abstract][Full Text] [Related]
6. Rapid initiation of gabapentin: a randomized, controlled trial. Fisher RS; Sachdeo RC; Pellock J; Penovich PE; Magnus L; Bernstein P Neurology; 2001 Mar; 56(6):743-8. PubMed ID: 11274308 [TBL] [Abstract][Full Text] [Related]
7. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety. Korn-Merker E; Borusiak P; Boenigk HE Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221 [TBL] [Abstract][Full Text] [Related]
9. Monotherapy trials with gabapentin for partial epilepsy. Beydoun A Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of gabapentin. Ramsay RE Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537 [TBL] [Abstract][Full Text] [Related]
12. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy. Goa KL; Sorkin EM Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432 [TBL] [Abstract][Full Text] [Related]
13. Dosing to efficacy with neurontin: the STEPS trial. Study of Titration to Effect Profile of Safety. Morrell MJ Epilepsia; 1999; 40 Suppl 6():S23-6; discussion S73-4. PubMed ID: 10530679 [TBL] [Abstract][Full Text] [Related]
18. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study. Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405 [TBL] [Abstract][Full Text] [Related]
19. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846 [TBL] [Abstract][Full Text] [Related]
20. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83. Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]